Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Doximity (DOCS) Non-Current Deffered Revenue (2021 - 2025)

Doximity has reported Non-Current Deffered Revenue over the past 5 years, most recently at $174000.0 for Q4 2025.

  • Quarterly Non-Current Deffered Revenue rose 138.36% to $174000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $174000.0 through Dec 2025, up 138.36% year-over-year, with the annual reading at $280000.0 for FY2025, 32.7% up from the prior year.
  • Non-Current Deffered Revenue was $174000.0 for Q4 2025 at Doximity, down from $263000.0 in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $349000.0 in Q2 2021 and troughed at $38000.0 in Q4 2021.
  • The 5-year median for Non-Current Deffered Revenue is $170000.0 (2022), against an average of $170900.0.
  • The largest YoY upside for Non-Current Deffered Revenue was 268.42% in 2022 against a maximum downside of 64.55% in 2022.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $38000.0 in 2021, then skyrocketed by 268.42% to $140000.0 in 2022, then rose by 18.57% to $166000.0 in 2023, then plummeted by 56.02% to $73000.0 in 2024, then soared by 138.36% to $174000.0 in 2025.
  • Per Business Quant, the three most recent readings for DOCS's Non-Current Deffered Revenue are $174000.0 (Q4 2025), $263000.0 (Q3 2025), and $118000.0 (Q2 2025).